• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO’s Access Roadmap And The Art Of Accommodation Of Pharma Interest

26/01/2019 by Intellectual Property Watch 1 Comment

The Roadmap to access to medicines, vaccines and other health products (Roadmap) to be discussed at this week’s 144th session of WHO’s Executive Board accommodates vital interest of pharmaceutical TNCs on critical issues such as the approach to access, technical assistance on the use of TRIPS flexibilities and access to biosimilars.

Adoption of the Roadmap in its current form very well accommodates the interest of the Pharmaceutical TNCs and therefore one need not expect any proactive steps by WHO towards promoting access after the adoption of the Roadmap.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO, WIPO, WTO/TRIPS

WHO Director Tedros: Innovation, Digital Health A Major Pillar In WHO Transformation

24/01/2019 by William New, Intellectual Property Watch 1 Comment

The World Health Organization is significantly upgrading its focus on digital health and innovation as it moves into a new era, renovating literally every aspect of the organisation, the WHO director general told member states today.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Information and Communications Technology/ Broadcasting, Innovation/ R&D, New Technologies, Patents/Designs/Trade Secrets, WHO

India, Ecuador, Peru Bring TRIPS Flexibilities Into WHO Universal Health Coverage Discussions

24/01/2019 by Catherine Saez, Intellectual Property Watch 1 Comment

Universal health coverage is a goal shared by all members of the World Health Organization. The ways to achieve that goal might however be based on different strategies. As members are working on a common resolution for the approval of the Executive Board of the organisation, and are contributing draft text, India brought up the intellectual property dimension by suggesting the text includes mention of the use of international trade rules flexibilities to protect public health.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Health & IP, Patents/Designs/Trade Secrets, WHO, WTO/TRIPS

WHO Cancer Report Stirs Debate On Eve Of Board Meeting

23/01/2019 by William New, Intellectual Property Watch 3 Comments

As the World Health Organization Executive Board gathers tomorrow for its annual January meeting, health industry and advocacy groups have seized on a WHO report to be presented to the Board that finds high prices for cancer medicines are “impairing” governments’ ability to provide affordable treatments. One issue they may have in common is a desire for more transparency in analyses of prices.

Filed Under: IP Policies, Themes, Venues, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, WHO

Special Report: Guide To This Week’s WHO Board Meeting – Budget, Medicines Access, Antimicrobial Resistance, NCDs, More

18/01/2019 by Catherine Saez, Intellectual Property Watch 1 Comment

The World Health Organization Executive Board this month will consider an 8 percent WHO budget increase for 2020-2021, discuss environment health risks, the high price of cancer drugs, and how to facilitate access to medicines and vaccines. Also on the agenda is the fight against antimicrobial resistance, rising noncommunicable diseases, and tuberculosis.

In another area, the Board is also expected to discuss its pandemic influenza framework, in particular access to influenza viruses under the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity. The Board will further be asked to consider new entities seeking to enter into official relationships with the WHO, and those with whom relations should be discontinued.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, English, Finance, Health & IP, Patents/Designs/Trade Secrets, WHO

Supporting UHC And Better Explaining IP – The 2019 Pharma Industry Agenda

16/01/2019 by Intellectual Property Watch 1 Comment

In 2019, IFPMA work will continue to focus on constructive engagement in supporting UHC and working with others to strengthen health care systems. The association will continue to engage with a range of stakeholders, particularly multilateral organizations, to better explain the benefits of IP and exchange ideas to address issues of coverage, capacity, affordability and sustainability of healthcare.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, English, Europe, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WHO

WHO Report Shows Global Progress On Influenza Preparedness Response

18/12/2018 by David Branigan, Intellectual Property Watch Leave a Comment

The World Health Organization has released a new report showing that significant progress has been made to build national and global preparedness for future influenza pandemics. This progress resulted from the collaborative multi-sectoral implementation of a WHO plan, funded by the benefit-sharing contributions of industry partners, to strengthen global health security against pandemic influenza.

Filed Under: IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Finance, Health & IP, Human Rights, Patents/Designs/Trade Secrets, WHO

WHO To Form Expert Panel On Challenges Of Human Gene Editing

17/12/2018 by Intellectual Property Watch 1 Comment

The World Health Organization has announced it will be establishing a global multidisciplinary panel of experts “to examine the scientific, ethical, social and legal challenges associated with human gene editing.”

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Health & IP, Human Rights, New Technologies, Patents/Designs/Trade Secrets, WHO

Experts Call For Global Accountability Mechanism For Access To Essential Medicines

10/12/2018 by Intellectual Property Watch 1 Comment

Global health experts, including senior officials at the World Health Organization, are calling for a global accountability mechanism for access to essential medicines, noting that a the lack of data on medicines affordability and national pharmaceutical expenditures has hindered this process, according a recent article published in UK medical journal The Lancet.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Europe, Health & IP, New Technologies, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WHO

Transparency Of Patent Status Key For Health Actors: Databases Presented At WIPO

05/12/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

Information on the status of patents can be key for medicines procurement agencies seeking to know if they can source cheaper generic products. Several databases providing free information on patent status were presented yesterday at the World Intellectual Property Organization. The World Health Organization, also invited, hailed the efforts, but warned against listing follow-on patents, which could confuse procurement professionals. And a prominent molecular biologist, chief executive of a patents-and-scholarly database, called for breaking silos to advance innovation.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Enforcement, English, Health & IP, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO, WIPO

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 114
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting